[Federal Register Volume 68, Number 65 (Friday, April 4, 2003)]
[Notices]
[Page 16516]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-8195]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Conference Call 
Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following joint conference call meeting 
of the Advisory Committee on Immunization Practices and its Smallpox 
Vaccine Safety Working Group.
    Name: Advisory Committee on Immunization Practices (ACIP) and ACIP 
Smallpox Vaccine Safety Working Group.
    Time and Date: 2 p.m.-4 p.m., March 28, 2003.
    Place: The conference call will originate at the National 
Immunization Program (NIP), in Atlanta, Georgia. Please see 
SUPPLEMENTARY INFORMATION for details on accessing the conference call.
    Status: Open to the public, limited only by the availability of 
telephone ports.
    Purpose: The Committee is charged with advising the Director, CDC, 
on the appropriate uses of immunizing agents.
    In addition, under 42 U.S.C. 1396s, the Committee is mandated to 
establish and periodically review and, as appropriate, revise the list 
of vaccines for administration to vaccine-eligible children through the 
Vaccines for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters to Be Discussed: The Advisory Committee on Immunization 
Practices and its Smallpox Vaccine Safety Working Group will convene by 
conference call to discuss whether to recommend to CDC that persons 
with a history of cardiac disease be deferred from smallpox vaccination 
during the pre-event phase of the national smallpox vaccination 
program.

SUPPLEMENTARY INFORMATION: This conference call is scheduled to begin 
at 2 p.m., Eastern Standard Time. To participate in the conference 
call, please dial 1-888-849-8924 and reference passcode ACIP. You will 
then be automatically connected to the call.
    As provided under 41 CFR 102-3.150(b), the public health urgency of 
this agency business requires that the meeting be held prior to the 
first available date for publication of this notice in the Federal 
Register.

Contact Person for More Information: Demetria Gardner, Epidemiology and 
Surveillance Division, National Immunization Program, CDC, 1600 Clifton 
Road, NE., (E-61), Atlanta, Georgia 30333, telephone 404/639-8096, fax 
404/639-8616.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the CDC and ATSDR.

    Dated: March 31, 2003.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 03-8195 Filed 4-3-03; 8:45 am]
BILLING CODE 4163-18-P